Topic: Stanford University
WASHINGTON (Reuters) - U.S. scientists have identified a new class of drugs that appear to block the hepatitis C virus from replicating in laboratory experiments, researchers said on Wednesday.The team discovered activity within a key protein of the hepatitis C virus (HCV) ...
Cancer cells can revert to harmless cells by switching off a single gene, shows a study of liver cancer in mice.. "We were definitely surprised that we could make liver cancer cells look like normal liver cells," says Dean Felsher at Stanford ...